Difference between revisions of "Template:CaveQT"

From Psychiatrienet
Jump to: navigation, search
Line 1: Line 1:
* During this switch ECG monitoring is advisable, because of possible QT interval prolongation.<ref>EMEA,[http://www.ncbi.nlm.nih.gov/pubmed/16096514?ordinalpos=6&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum abilify] 2009</ref>
+
* During this switch ECG monitoring is advisable, because of possible QT interval prolongation.<ref>
 +
Stöllberger C, Huber JO, Finsterer J,[http://www.ncbi.nlm.nih.gov/pubmed/16096514?ordinalpos=6&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum Antipsychotic drugs and QT prolongation.] Int Clin Psychopharmacol. 2005 Sep;20(5):243-51. </ref>

Revision as of 15:23, 18 August 2009

  • During this switch ECG monitoring is advisable, because of possible QT interval prolongation.[1]
  • Stöllberger C, Huber JO, Finsterer J,Antipsychotic drugs and QT prolongation. Int Clin Psychopharmacol. 2005 Sep;20(5):243-51.